Related Experiment Video
Updated: Feb 27, 2026

Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
Published on: May 24, 2017
Do E-cigarettes induce weight changes and increase cardiometabolic risk? A signal for the future
1Department of Endocrinology, Diabetology and Metabolism, Antwerp University Hospital, Edegem, Belgium.
Electronic cigarette use, or vaping, is rising, particularly among young people. This review examines vaping
Area of Science:
- Cardiometabolic Health
- Tobacco Harm Reduction
- Metabolic Syndrome
Background:
- Electronic cigarette use (vaping) is increasing, marketed as a safer alternative to conventional cigarettes.
- Conventional smoking impacts weight, insulin resistance, and cardiometabolic risk.
- The metabolic effects of vaping compared to smoking are not fully understood in humans.
Purpose of the Study:
- To review existing data on the effects of e-cigarette use on weight and cardiometabolic parameters.
- To propose mechanistic hypotheses for observed effects.
Main Methods:
- Literature review of published studies on vaping and metabolic/cardiometabolic outcomes.
- Analysis of data from human and animal models.
Main Results:
- Animal studies suggest vaping may have similar metabolic effects to smoking, even without nicotine.
- Limited human data exists, necessitating further research.
Conclusions:
- Vaping's impact on weight and cardiometabolic health requires thorough investigation.
- Mechanistic understanding is crucial for assessing vaping's long-term health risks.
More Related Videos
08:39Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
Published on: August 25, 2018
09:30A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
Published on: January 18, 2018
Related Concept Videos
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Stress Prevention and Stress Management Techniques IV
Coronary Artery Disease I: Introduction
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Obesity
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...